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Abstract. 
 
The 17S U2 small nuclear ribonucleoprotein 
particle (snRNP) represents the active form of U2
snRNP that binds to the pre-mRNA during spliceo-
some assembly. This particle forms by sequential inter-
actions of splicing factors SF3b and SF3a with the 12S 
U2 snRNP. We have puriﬁed SF3b and the 15S U2
snRNP, an intermediate in the assembly pathway, from 
HeLa cell nuclear extracts and show that SF3b consists 
of four subunits of 49, 130, 145, and 155 kD. Biochemi-
cal analysis indicates that both SF3b and the 12S
U2 snRNP are required for the incorporation of SF3a 
into the 17S U2 snRNP. Nuclease protection studies 
demonstrate interactions of SF3b with the 5
 
9
 
 half of U2 
small nuclear RNA, whereas SF3a associates with the 
3
 
9
 
 portion of the U2 snRNP and possibly also interacts 
with SF3b. Electron microscopy of the 15S U2 snRNP 
shows that it consists of two domains in which the char-
acteristic features of isolated SF3b and the 12S U2
snRNP are conserved. Comparison to the two-domain 
structure of the 17S U2 snRNP corroborates the bio-
chemical results in that binding of SF3a contributes to 
an increase in size of the 12S U2 domain and possibly 
induces a structural change in the SF3b domain.
Key words: electron microscopy • pre-mRNA splicing 
• spliceosome • splicing factor • U2 small nuclear ribo-
nucleoprotein particle
 
I
 
NTRONS
 
 are removed from nuclear pre-mRNAs in
large complexes, termed spliceosomes, that are as-
sembled by a network of interactions between the
pre-mRNA, small nuclear ribonucleoprotein particles (sn-
RNPs),
 
1
 
 and non-snRNP proteins (for review see Moore
et al., 1993; Madhani and Guthrie, 1994). The RNA moi-
eties of the snRNPs base pair with conserved sequences at
the splice sites and the intron branch site and also with one
another, thus generating the catalytic core of the spliceo-
some. snRNP and non-snRNP proteins are essential for
splicing, although they are probably not directly involved
in catalysis (for review see Krämer, 1996).
snRNPs were initially isolated from mammalian cells
under high salt conditions as complexes of 10–12S, con-
taining a set of eight common (Sm or core) proteins and a
limited number of proteins that are characteristic for each
snRNP (for review see Will and Lührmann, 1997). Milder
purification procedures have later led to the detection of
larger snRNP complexes containing varying numbers of
additional polypeptides.
The U2 snRNP has been isolated in two forms of 12 and
17S. The 12S U2 snRNP contains the Sm proteins and two
characteristic proteins, A
 
9
 
 and B
 
99
 
. The Sm proteins are
bound to a structural motif, the Sm binding site, which
consists of a single-stranded region of the sequence
RA(U)
 
n
 
GR (
 
n
 
 
 
$
 
 3) flanked by double-stranded stems
(see Fig. 4 B; Branlant et al., 1982; Mattaj and De Rober-
tis, 1985). The A
 
9
 
 and B
 
99
 
 proteins are bound to the 3
 
9
 
 ter-
minal stem-loop IV of U2 small nuclear RNA (snRNA)
 
(Scherly et al., 1990; Bentley and Keene, 1991; Boelens
et al., 1991; Price et al., 1998). The 17S U2 snRNP, which
was isolated at salt concentrations 
 
,
 
200 mM, contains
nine additional proteins of 35, 53, 60, 66, 92, 110, 120, 150,
and 160 kD (Behrens et al., 1993b).
Electron microscopy revealed two tightly attached do-
mains in the 12S U2 snRNP (Kastner et al., 1990). A main
body (or core domain) of 
 
z
 
8 nm in diameter comprises
the Sm proteins. The A
 
9
 
 and B
 
99
 
 proteins are present in an
additional domain 4 nm in length and 6 nm in width which
 
is directly attached to the core domain. The 17S U2 snRNP
 
consists of two distinct globular domains of 
 
z
 
10–12 nm
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1. 
 
Abbreviations used in this paper:
 
 PAS, protein A–Sepharose; SAP, spli-
ceosome-associated protein; SF, splicing factor; snRNA, small nuclear
RNA; snRNP, small nuclear ribonucleoprotein particle. 
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which differ in their appearance and are connected by a
short filamentous structure that is sensitive to RNase
(Behrens et al., 1993b). The fine structure of the 12S U2
snRNP was not evident in either of these domains and it
appeared that both domains of the 17S U2 snRNP con-
tained one or more of the additional 17S U2 snRNP-spe-
cific proteins.
In vitro, the 17S U2 snRNP is reconstituted by incuba-
tion of the 12S U2 snRNP with splicing factors (SF) 3a and
3b (Brosi et al., 1993a) that were initially isolated as non-
snRNP proteins (Brosi et al., 1993b). The 12S U2 snRNP
and SF3b associate to form a particle of 15S; addition of
SF3a to the 15S U2 snRNP results in the assembly of the
17S particle. Biochemical and immunological analyses
have confirmed that the three subunits of SF3a (SF3a60,
SF3a66, and SF3a120) represent the 17S U2 snRNP-spe-
cific proteins of 60, 66, and 110 kD (Brosi et al., 1993a). In
a separate study, a U2 snRNP-specific patient serum pre-
cipitated seven spliceosome-associated proteins (SAPs)
from a fraction enriched in U2 snRNP (Staknis and Reed,
1994). Three of these (SAP61, SAP62, and SAP114) corre-
spond to the SF3a subunits, whereas the other proteins
(SAP49, SAP130, SAP145, and SAP155) are similar in size
to the 17S U2-specific polypeptides of 53, 120, 150, and
160 kD. Together these studies suggested that SAP49,
SAP130, SAP145, and SAP155 and possibly the two re-
maining 17S U2 snRNP-specific proteins of 35 and 92 kD
are constituents of SF3b.
U2 snRNP functions in splicing by converting the early
complex E into presplicing complex A (for review see
Krämer, 1996; Reed, 1996). Complex E is formed by bind-
ing of U1 snRNP to the 5
 
9
 
 splice site and interaction of
splicing factors U2AF and SF1 with the polypyrimidine
tract upstream of the 3
 
9
 
 splice site and the branch site, re-
spectively. The formation of complex A occurs by subse-
quent binding of U2 snRNP to the pre-mRNA, which
involves the formation of a short helix between a single-
stranded region in U2 snRNA (the branch site interaction
sequence; shown in bold in Fig. 4 B) and the intron branch
site. This reaction requires the 12S U2 snRNP plus SF3a
and SF3b (Brosi et al., 1993b) or the isolated 17S U2 sn-
RNP (Behrens et al., 1993a); the 12S U2 snRNP alone is
inactive in complex assembly. Thus, SF3a and SF3b are es-
sential for prespliceosome assembly in combination with
the 12S U2 snRNP. It has furthermore been shown that
SF3a and three of the presumptive SF3b polypeptides
cross-link to the pre-mRNA in the vicinity of the branch
site during A complex assembly (Gozani et al., 1996,
1998). These interactions are thought to stabilize the U2
snRNA/branch site helix and may also aid to incorporate
the U2 snRNP into the spliceosome.
Functions for U2 snRNP-associated proteins at later
stages of the splicing reaction have not been reported.
However, the U2 snRNA plays a vital role in the forma-
tion of the active site of the spliceosome. Sequences up-
stream and downstream of the branch site interaction
sequence engage in base pairing interactions with U6
snRNA that are essential for intron removal (for review
see Madhani and Guthrie, 1994; Yu et al., 1999). Base
pairing between U2 and U6 snRNA necessitates the desta-
bilization of stem-loops I and IIa in U2 snRNA as well as
sequences in U6 that are base-paired to U4 snRNA, which
 
is most likely achieved by the action of RNA-dependent
ATPases (for review see Staley and Guthrie, 1998).
The purpose of the present study was to determine the
subunit composition of SF3b and the roles of SF3a and
SF3b in the formation of the 17S U2 snRNP. Protein–pro-
tein interactions between individual SF3a subunits and
SAP49 and SAP145 have been described and are con-
served in 
 
Saccharomyces cerevisiae
 
 (Krämer, 1996; Fro-
mont-Racine et al., 1997; Igel et al., 1998). However, it is
not known whether SF3a and SF3b interact with one an-
other in the absence of other components of the 17S U2
snRNP. In addition, several studies have addressed the in-
teraction of proteins with the U2 snRNA. First, Temsa-
mani et al. (1991) showed that sequences in the 5
 
9
 
 half of
U2 snRNA and stem-loop IV are required for the forma-
tion of a complex of low mobility that most likely corre-
sponds to the 17S U2 snRNP. Second, biochemical and
electron microscopic studies by Behrens et al. (1993b) sug-
gested that most of the 17S U2 snRNP-specific proteins as-
sociated with the 5
 
9
 
 portion of the U2 particle. Third, stud-
ies in 
 
S
 
.
 
 cerevisiae
 
 indicated genetic interactions between
stem-loops IIa and IIb and homologues of the SF3a
polypeptides and between stem-loop IIa and Cus1p, the
homologue of SAP145 (Ruby et al., 1993; Wells and Ares,
1994; Wells et al., 1996; Yan and Ares, 1996).
We have used a biochemical approach to analyze inter-
actions that occur during the assembly of the 17S U2 sn-
RNP and to position SF3a and SF3b within this particle.
These studies were complemented by a comparison of the
morphology of the 15S U2 snRNP and SF3b by electron
microscopy. Based on these results we propose a model of
the principle architecture of the U2 snRNP particle.
 
Materials and Methods
 
RNAs and Oligonucleotides
 
The template for the pre-mRNA substrate (T3-RNA1) has been de-
scribed (Arning et al., 1996). Human antisense U2 snRNA was tran-
scribed with T7 polymerase from a pGem-U2 construct digested with
EcoRI (Lamond et al., 1989). 2
 
9
 
-
 
O
 
-allyl oligoribonucleotides complemen-
tary to U2 snRNA were generous gifts from Angus Lamond (University
of Dundee, Dundee, UK) and have been described by Barabino et al.
(1992). The Sm and C
 
9
 
 oligodeoxynucleotides are complementary to nu-
cleotides 84–107 and 148–174 of U2 snRNA, respectively.
 
Preparation of Splicing Factors and snRNPs
 
Splicing factors and snRNPs were fractionated from HeLa cell nuclear ex-
tracts by DEAE-Sepharose, heparin-Sepharose, and Mono Q chromatog-
raphy as described (Krämer et al., 1987; Krämer and Utans, 1991). SF3a
and SF3b were further purified by spermine-agarose and Mono S chroma-
tography (Brosi et al., 1993b). In addition, SF3b (Mono S), U1, and U2 sn-
RNPs (Mono Q) were sedimented in glycerol gradients. Fractions were
adjusted to 10% glycerol and layered onto 4-ml gradients of 15–40% glyc-
erol in 100 mM KCl, 20 mM Hepes-KOH (pH 7.9), 1 mM MgCl
 
2
 
, 0.5 mM
PMSF, 0.5 mM DTT, and 0.2 mM EDTA. Sedimentation was performed
in a TST60.4 rotor (Kontron) for 8 h at 55,000 rpm. Fractions of 200 
 
m
 
l
were collected from the top.
 
In Vitro Assembly of U2 snRNP Complexes
and Prespliceosomes
 
U2 snRNPs complexes were assembled in the presence of SF3a and SF3b
(Mono S fractions) and the 12S U2 snRNP (Mono Q) as described (Brosi
et al., 1993a). The formation of presplicing complexes was performed in
the presence of HeLa cell nuclear extract or partially purified splicing 
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factors (Krämer, 1988): SF1, ammonium sulfate–concentrated DS100
(Krämer, 1992); SF3a, Mono S (Brosi et al., 1993b); U2AF, HS1000
(Krämer and Utans, 1991), U1 snRNP purified by glycerol gradient cen-
trifugation (see above), and the fractions indicated in the figure legends.
 
Immunoprecipitation
 
IgG from monoclonal anti-SF3a66 antibody (mAb66; Brosi et al., 1993b)
was bound to protein A–Sepharose (PAS) in NET-2 buffer (50 mM Tris-
HCl, pH 7.9, 150 mM NaCl, 0.5 mM DTT, 0.5% NP-40) for 1 h at 4
 
8
 
C. The
material was washed with NET-2 to remove unbound IgG. PAS-coupled
antibodies were incubated with combinations of SF3a, SF3b, and U2 sn-
RNP for 90 min at 4
 
8
 
C. Unbound material was removed by washing with
NET-2 and the samples were divided into three aliquots. Bound compo-
nents were eluted with SDS sample solution from two aliquots each and
separated by SDS-PAGE. Proteins were either stained with silver or blot-
ted onto nitrocellulose membranes followed by detection of the U2 sn-
RNP-specific protein B
 
99
 
 with mAb4G3 (a gift from W. van Venrooij,
University of Nijmegen, Nijmegen, The Netherlands) and Sm proteins
with mAbY12 (a gift from J. Steitz, Yale University, New Haven, CT) as
described (Brosi et al., 1993b). The third set of aliquots was treated with
proteinase K (0.35 mg/ml proteinase K, 2% sarcosyl, 0.1 M Tris-HCl, pH
7.5, 20 mM EDTA) for 30 min at 60
 
8
 
C to release bound U2 snRNA, fol-
lowed by phenol-chloroform extraction and ethanol precipitation. RNA
was separated in a 14% polyacrylamide/8.3 M urea gel followed by North-
ern blotting and detection with radiolabeled antisense U2 snRNA as de-
scribed below.
 
Protection from Micrococcal Nuclease Digestion and 
Analysis by Northern Blotting
 
U2 snRNP fractions isolated from HeLa cell nuclear extracts or reconsti-
tuted from individual purified components were digested with micrococ-
cal nuclease for 10 min at 30
 
8
 
C (Krämer et al., 1987). RNA was isolated by
proteinase K digestion, separated in 14% polyacrylamide/8.3 M urea gels,
and blotted onto GeneScreen membranes (Schleicher and Schüll) as de-
scribed (Utans et al., 1992). RNA was cross-linked to the membranes by
UV irradiation in a Stratalinker (Stratagene) and the membranes were
prehybridized in 5
 
3
 
 SSC, 5
 
3
 
 Denhardt’s solution, 1% SDS, 2.5% dextran
sulfate, 50 mM sodium phosphate (pH 6.5), and 1 mg/ml salmon sperm
DNA. The membranes were hybridized overnight in the same solution
with uniformly labeled antisense U2 snRNA or 5
 
9
 
 endlabeled oligonucle-
otides at 25–40
 
8
 
C (depending on the oligonucleotides) followed by several
washes in 2
 
3
 
 SSC/1% SDS at 25
 
8
 
C.
 
Electron Microscopy
 
Glycerol gradient fractions containing purified U2 snRNPs or SF3b were
negatively stained with 2.5% uranyl formate by the double carbon film
method as described (Kastner and Lührmann, 1989; Kastner, 1998). The
preparations were examined under a Zeiss EM109 electron microscope
with an acceleration voltage of 80 kV and electron micrographs were
taken with a magnification of 85,000.
 
Results
 
Different Forms of the U2 snRNP Are Separated by 
Mono Q Chromatography
 
The majority of the U2 snRNP in HeLa cell nuclear ex-
tracts sediments with 
 
z
 
17S in glycerol gradients (at 100 mM
KCl) and most SF3a is found in the same gradient frac-
tions (Brosi et al., 1993a). In contrast, after chromatogra-
phy of nuclear extracts on DEAE-Sepharose, heparin-
Sepharose, and Mono Q, SF3a and SF3b activity was
detected in snRNP-free fractions eluting at 
 
z
 
0.2–0.28 M
KCl (Krämer et al., 1987). In Western blots with antibod-
ies directed against SF3a or SF3b subunits, the bulk of
these proteins is found in the same fractions and only
small amounts elute at higher salt concentrations (data not
shown). U2 snRNP elutes from Mono Q in a highly repro-
ducible heterogeneous pattern at salt concentrations 
 
.
 
0.3 M
(Fig. 1 A; Krämer et al., 1987). To test whether this hetero-
geneity resulted from a separation of the different forms
of U2 snRNP, snRNPs of the Mono Q fractions were sepa-
rated by nondenaturing PAGE (Fig. 1 B). To visualize U2
snRNPs by autoradiography Mono Q fractions were incu-
bated with a 5
 
9
 
 endlabeled oligoribonucleotide comple-
mentary to the 5
 
9
 
 end of U2 snRNA (U2A; see Fig. 4 B)
before gel electrophoresis. U2 snRNP eluting at 
 
z
 
0.3 M
KCl (fractions 34–38) migrated similar to U2 snRNP in
nuclear extracts and a 17S U2 snRNP control obtained af-
ter glycerol gradient sedimentation. U2 snRNP eluting at
0.4 M KCl (fractions 48–50) corresponded in mobility to a
particle formed in vitro with the 12S U2 snRNP and a
SF3b-containing fraction (see Fig. 4 A; Brosi et al., 1993a),
thus representing the 15S U2 snRNP. Most U2 snRNP
Figure 1. Separation of different forms of U2 snRNP by Mono Q
chromatography. (A) RNA from 20-ml aliquots of HeLa cell nu-
clear extract and Mono Q fractions was isolated by proteinase K
digestion, phenol-chloroform extraction, and ethanol precipita-
tion, separated in a 10% polyacrylamide/8.3 M urea gel, and
stained with ethidium bromide. snRNAs and 5S RNA are indi-
cated on the right. (B) Aliquots (5 ml) of HeLa cell nuclear ex-
tract (NE), glycerol gradient–purified 17S and 12S U2 snRNPs,
and Mono Q fractions were incubated with 59 endlabeled oligo-
nucleotide U2A (see Fig. 4 B) and separated in a 4% polyacryl-
amide gel (Brosi et al., 1993a). The different forms of U2 snRNP
are indicated on the right. 
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eluted at high salt concentration (
 
z
 
0.48 M KCl; fractions
54–60) and its migration corresponded to that of the 12S
U2 particle. Thus, a large portion of SF3a and SF3b disso-
ciates from the 17S U2 snRNP during the fractionation
procedure, which is consistent with the observation that
the 17S U2 snRNP is disrupted at salt concentrations 
 
.
 
200
mM (Behrens et al., 1993b; Brosi et al., 1993a).
 
Identification of Polypeptides Associated with SF3b
 
As a first step in the identification of SF3b-associated
polypeptides, Mono Q fractions containing the 15S U2 sn-
RNP (which by definition should contain the Sm proteins,
A
 
9
 
, B
 
99
 
, and SF3b; see Introduction) were sedimented in a
glycerol gradient. Individual gradient fractions were ana-
lyzed for their RNA and protein composition. The major-
ity of U2 snRNA is detected in fractions 10–13 (Fig. 2 A)
and the same fractions are highly enriched in polypeptides
of 
 
z
 
130–150 kD (Fig. 2 B, arrowheads). In addition, a
polypeptide of 
 
z
 
50 kD cofractionates with U2 snRNA.
We next tested whether the glycerol gradient fractions
containing U2 snRNA were active in the assembly of pre-
splicing complex A, i.e., could substitute for both, the 12S
U2 snRNP and SF3b. Reactions were performed in the
presence of SF1, SF3a, U2AF, and U1 snRNP which are
required for presplicing complex formation in addition to
SF3b and U2 snRNP (Krämer and Utans, 1991; Brosi et al.,
1993b). Complex A was efficiently assembled in the pres-
ence of partially purified U2 snRNP and SF3b or the
Mono Q 15S U2 snRNP fraction used as the input for
glycerol gradient sedimentation, but complex A was not
formed in the absence of U2 snRNP and SF3b (Fig. 2 C).
Addition of glycerol gradient fractions 10–14 to the recon-
stitution reaction promoted the assembly of the complex.
Complex formation was not observed when only SF3b was
omitted from a spliceosome assembly reaction (Brosi et al.,
1993b); thus, we conclude that the 15S U2 snRNP frac-
tions contain functional U2 snRNP and SF3b.
Figure 2. Analysis of glyc-
erol gradient–purified 15S
U2 snRNP. The 15S U2 sn-
RNP (Mono Q) was sedi-
mented through a 15–40%
glycerol gradient. (A) RNA
from individual gradient
fractions was separated in a
10% polyacrylamide/8.3 M
urea gel and stained with
ethidium bromide. snRNAs
are indicated on the left. (B)
Proteins were separated in a
10% SDS polyacrylamide gel
and stained with silver. The
SF3b subunits are indicated
by arrows. (C) The 12S U2
snRNP (Mono Q) and SF3b
(Mono S), the 15S U2 sn-
RNP (Mono Q; IP), and glyc-
erol gradient fractions of the
15S U2 snRNP were ana-
lyzed for presplicing complex
formation in the presence of
SF1, SF3a, U2AF, and U1
snRNP (see Materials and
Methods). A control reaction
with nuclear extract (NE) is
shown in the second lane.
The migration of pre-mRNA
and presplicing complex A is
indicated on the left. (D)
Glycerol gradient–purified
SF3b and 15S U2 snRNP
were separated in a 10%
SDS polyacrylamide gel. Ar-
rows indicate the SF3b sub-
units. The U2-specific pro-
teins A9 and B99 are
indicated by lines; size mark-
ers are shown on the left. 
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We also sedimented partially purified SF3b (Mono S
fraction; Brosi et al., 1993b) in glycerol gradients. This step
yielded fractions with extremely low activity in A complex
formation (data not shown). Loss of activity could have
been caused by dilution or inactivation of SF3b during
centrifugation or by loss of another component(s) required
for spliceosome assembly (see Discussion). As shown in
Fig. 2 D, however, the protein content of glycerol gradi-
ent–purified SF3b with residual activity in complex forma-
tion and the purified 15S U2 snRNP was similar. Four pro-
teins of 
 
z
 
50, 130, 140, and 155 kD are present in both
fractions. A polypeptide of 120 kD present in the 15S U2
snRNP is barely visible in SF3b. This protein is consis-
tently coimmunoprecipitated with the 15S U2 snRNP, but
is absent from the 17S U2 particle and does not represent
SF3a120 (Nesic, D., and A. Krämer, unpublished observa-
tion). At present, it is unknown whether this protein rep-
resents a contamination or a 15S U2 snRNP-associated
protein. A candidate for a specifically bound protein is
Tat-SF1, the human orthologue of Cus2p which has been
found associated with the U2 snRNP and interacts with
SF3a (Yan et al., 1998). Two proteins of 29.5 and 28.5 kD
present in the 15S U2 snRNP represent the U2 snRNP-
specific A
 
9
 
 and B
 
99
 
 proteins. These proteins are absent
from SF3b fractions as confirmed by Western blotting with
specific antibodies (see Fig. 3 B, lane 2; data not shown).
From these results we conclude that SF3b comprises four
subunits of 50, 130, 140, and 155 kD, which is further cor-
roborated by immunoprecipitation experiments (see be-
low). It is highly likely that the SF3b subunits correspond
to the polypeptides of 53, 120, 150, and 160 kD found asso-
ciated with the 17S U2 snRNP (Behrens et al., 1993b) and
to SAP49, 130, 145, and 155 detected by immunoprecipita-
tion with anti-U2 snRNP antibodies (Staknis and Reed,
1994). In accordance with the sizes determined for the U2
snRNP-associated SAPs (Bennett et al., 1992; Staknis and
Reed, 1994), the SF3b subunits will be referred to as
SF3b49, 130, 145, and 155.
 
Interactions Required for the Assembly of the
17S U2 snRNP
 
By nondenaturing PAGE we have shown previously that
incorporation of SF3a into the U2 snRNP requires the
presence of SF3b (Brosi et al., 1993a). In these experi-
ments weak contacts between the 12S U2 snRNP and
SF3a could have been disrupted during gel electrophore-
sis. Moreover, interactions between SF3a and SF3b could
not be tested. We have addressed these issues in an immu-
noprecipitation experiment. A monoclonal antibody di-
rected against SF3a66 (mAb66; Brosi et al., 1993b) was
coupled to PAS and incubated with different combina-
tions of partially purified SF3a, SF3b, and the 12S U2 sn-
RNP (Fig. 3 A, lanes 1–3). Immunoprecipitates were ana-
lyzed for the presence of SF3a and SF3b subunits by SDS
PAGE (Fig. 3 A). Other U2 snRNP-associated proteins
were detected by Western blotting with antibodies di-
rected against the U2 snRNP-specific protein B
 
99
 
 (Fig. 3
B) and the Sm proteins (Fig. 3 C). The presence of U2 sn-
RNA was analyzed by Northern blotting with radioac-
tively labeled antisense U2 snRNA (Fig. 3 D). mAb66 spe-
cifically precipitated the proteins of 60, 66, and 120 kD
 
from the SF3a fraction (lane 6), whereas no polypeptides
were precipitated from control reactions containing SF3b
and the 12S U2 snRNP (lanes 7 and 8). When SF3a, SF3b,
and the 12S U2 snRNP were combined, the SF3a subunits,
the proteins found in purified SF3b, B, B
 
9
 
, and B
 
99
 
 and U2
snRNA were precipitated by mAb66, consistent with the
formation of the 17S U2 snRNP (lane 12). In contrast,
from reactions in which SF3a was incubated with either
SF3b or the 12S U2 snRNP, only the SF3a subunits were
precipitated (lanes 9 and 10). These results confirm that
both the 12S U2 snRNP and SF3b are essential for the in-
corporation of SF3a into the particle (Brosi et al., 1993a).
Furthermore, SF3a and SF3b do not detectably associate
with one another in the absence of the 12S U2 snRNP.
Thus, the SF3a interaction site is generated upon binding
of SF3b to the 12S U2 snRNP.
A requirement of U2 snRNA for the formation of the
17S U2 snRNP was tested by digestion of U2 snRNA with
micrococcal nuclease at different stages of the assembly
reaction. When the 12S U2 snRNP (Fig. 3, lane 13) or a
combination of SF3b and the 12S U2 snRNP (lane 14) was
digested with micrococcal nuclease before the addition of
the remaining components, neither the SF3b subunits nor
the 12S U2 snRNP proteins were precipitated by mAb66.
However, when the digestion was performed after prein-
cubation of SF3a, SF3b, and the 12S U2 snRNP (lane 15),
i.e., after the 17S U2 snRNP had been formed, SF3a, SF3b,
and 12S U2 snRNP-associated proteins were found in the
mAb66 precipitates and no intact U2 snRNA was de-
tected. These results indicate that the U2 snRNA is re-
quired for the formation of the 15S and 17S U2 snRNP
particles, but once the 17S U2 snRNP is formed, SF3a,
SF3b, and the 12S U2 snRNP proteins remain associated
with one another in the absence of intact U2 snRNA.
 
Nuclease Protection Analysis Positions SF3b in the
5
 
9
 
 Half and SF3a in the 3
 
9
 
 Half of the U2 snRNP
 
In the Northern blot shown in Fig. 3 D the U2 snRNA
was not completely digested, but distinct RNA fragments
were protected from micrococcal nuclease digestion (not
shown). We exploited this observation to analyze the por-
tions in U2 snRNA that are inaccessible to micrococcal
nuclease in the 12S, 15S, and 17S U2 snRNPs due to the
binding of proteins. We first determined concentrations of
SF3a, SF3b, and the 12S U2 snRNP that allow for the effi-
cient assembly of the 15S and 17S U2 snRNPs without
cross-contamination. Fig. 4 A shows that the 12S U2 sn-
RNP was converted quantitatively into the 15S U2 snRNP
at the highest concentration of SF3b. Efficient assembly of
the 17S U2 snRNP was achieved at the highest concentra-
tion of SF3a. No 15S U2 snRNP was detected and only
a minor contaminating complex that migrated slightly
slower in the native gel than the 12S U2 snRNP was seen.
This complex has not been analyzed further.
For the protection experiment the 12S U2 snRNP
(Mono Q) and 15S and 17S U2 snRNPs assembled under
the conditions established above were subjected to micro-
coccal nuclease digestion. RNA was isolated from un-
treated and micrococcal nuclease-digested samples and
processed for Northern blotting with radioactively labeled
oligonucleotides complementary to different regions of 
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U2 snRNA (Fig. 4 C; see Fig. 4 B for oligonucleotides).
Protected RNA fragments in the 12S U2 snRNP were only
observed with oligonucleotides that are complementary to
the 3
 
9
 
 half of U2 snRNA. The Sm oligonucleotide detected
a smear of RNA at the bottom of the gel, possibly result-
ing from protection of the Sm-binding site by the Sm pro-
teins (Mattaj and De Robertis, 1985). A smaller doublet
and a larger fragment hybridized to oligonucleotide C
 
9
 
(stem-loop IV); the larger fragment was also detected with
oligonucleotide J (stem-loop III). The protection of stem-
loop IV of U2 snRNA in the 12S U2 snRNP is consistent
with the binding of the U2 snRNP-specific proteins A
 
9
 
 and
B
 
99
 
 to this region (Scherly et al., 1990; Bentley and Keene,
1991; Boelens et al., 1991). A protection of stem-loop III
was not necessarily expected. However, Hamm et al.
(1989) found that deletion of stem-loop III of U2 snRNA
resulted in a destabilization of the binding of the A
 
9
 
 and
B
 
99
 
 proteins in 
 
Xenopus
 
 oocytes, suggesting that stem-loop
III influences the binding of these proteins. In addition,
Reveillaud et al. (1984) observed a comparable protection
even at higher micrococcal nuclease concentrations than
those used here.
In the 15S U2 snRNP several protected fragments were
detected with oligonucleotides A (stem-loop I) and D
(stem-loop IIa). The largest of these fragments also hy-
bridized very weakly with oligonucleotide H (stem-loop
IIb). (The weak hybridization of oligonucleotide H to this
fragment as compared with full-length U2 snRNA could
be explained if micrococcal nuclease cleaved within the re-
gion complementary to the oligonucleotide, thereby re-
ducing the efficiency of hybridization to the remaining se-
quences.) Thus, binding of SF3b leads to a protection of
the U2 snRNA in a region from stem-loop I to stem-loop
IIa, which possibly extends into stem-loop IIb, indicating
that the SF3b-binding site is located in the 5
 
9
 
 half of U2 sn-
RNA. In addition, the protection in the 3
 
9
 
 half of U2 sn-
RNA changed. The short doublet of fragments that hy-
bridized to oligonucleotide C
 
9
 
 in the 12S U2 snRNP was
no longer apparent and the fragment detected with C
 
9
 
 and
J appeared more intense. Furthermore, oligonucleotides J
and C
 
9
 
 hybridized to a larger doublet of fragments in the
15S U2 snRNP. A faint hybridization was also detected
with oligonucleotide Sm, suggesting that the protection ex-
tended from stem-loop IV to the Sm-binding site. These
changes could be caused either by direct contacts of SF3b
with this region or a conformational change in the 3
 
9
 
 half
of the U2 snRNP upon binding of SF3b that results in in-
creased protection from micrococcal nuclease digestion by
the U2A
 
9
 
 and B
 
99
 
 and/or the Sm proteins.
Binding of SF3a to the 15S U2 snRNP resulted in quali-
tative changes in the protection pattern of the 3
 
9
 
 half of U2
snRNA as apparent after digestion of the 17S U2 particle.
 
Figure 3.
 
Immunoprecipitation analysis of interactions between
SF3a, SF3b, and the 12S U2 snRNP. Combinations of fractions
containing SF3a (Mono S), SF3b (Mono S), and the 12S U2 sn-
RNP (Mono Q) were incubated for 15 min at 30
 
8
 
C (Brosi et al.,
1993a) followed by precipitation with mAb66 bound to PAS. (A)
Aliquots of untreated components or material bound to PAS
were separated in a 10% SDS polyacrylamide gel and stained
with silver. Lanes 1–3, input fractions of SF3a, SF3b, and the 12S
 
U2 snRNP (representing one-third of the material used in the im-
munoprecipitations). Lane 4, control reaction of reconstituted
17S U2 snRNP bound to PAS in the absence of mAb66. Lanes
5–12, immunoprecipitation in the presence of the fractions indi-
cated. Lane 13, the 12S U2 snRNP was treated with micrococcal
nuclease (MN) before incubation with SF3a and SF3b. Lane 14,
SF3b and the 12S U2 snRNP were incubated for 15 min at 30
 
8
 
C,
and treated with micrococcal nuclease followed by addition of
SF3a and immunoprecipitation. Lane 15, SF3a, SF3b, and the 12S
U2 snRNP were incubated for 15 min at 30
 
8
 
C, and treated with
micrococcal nuclease followed by immunoprecipitation with
mAb66-PAS. Lane 16, control immunoprecipitation of endoge-
nous 17S U2 snRNP. Lane 17, glycerol gradient–purified 15S U2
snRNP. The SF3a and SF3b subunits are indicated on the right of
the figure by arrowheads and arrows, respectively. The protein
indicated by H represents the heavy chain of mAb66 IgG and
two proteins indicated by closed circles are contaminants present
in the mAb66 preparation. Protein size standards are shown on
the left. (B and C) Aliquots of untreated components or material
bound to PAS were separated in a 13% SDS polyacrylamide gel,
blotted to nitrocellulose and incubated with mAb4G3 (anti-B
 
99
 
,
panel B) or mAbY12 (anti-Sm, panel C; only the staining of the
Sm proteins B and B
 
9
 
 is shown). The migration of U2B
 
99
 
, Sm pro-
teins B and B
 
9
 
, and the mAb66 light chain (L) is indicated. (D)
RNA from HeLa cell nuclear extract (NE), the 12S U2 snRNP,
the 12S U2 snRNP treated with micrococcal nuclease (MN-12S),
and from the material bound to PAS was separated in a 14%
polyacrylamide/8.3 M urea gel and blotted to a nylon membrane.
U2 snRNA was detected with radiolabeled antisense U2 snRNA. 
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Figure 4. Analysis of micrococcal nuclease-resistant regions in U2 snRNA in the 12S, 15S, and 17S U2 snRNPs. (A) In vitro reconstitu-
tion of the 15S and 17S U2 snRNPs. The indicated amounts (in microliters) of nuclear extract (NE), SF3a, SF3b, and the 12S U2 snRNP
were incubated with 59 endlabeled oligonucleotide U2A and separated in a 4% polyacrylamide gel. The position of the 15S and 17S U2
snRNPs is indicated on the right. (B) Secondary structure of mammalian U2 snRNA (according to Ares and Igel, 1990; Hartshorne and
Agabian, 1990). The Sm-binding site is underlined, the branch site interaction sequence is shown in bold, and the stem-loops are indi-
cated by roman numerals. Sequences complementary to oligonucleotides are shown by thick lines. (C) Analysis of protected fragments
of U2 snRNA in the 12S, 15S, and 17S particles by Northern blotting. The 12S U2 snRNP (Mono Q) and reconstituted 15S and 17S U2
snRNPs were incubated in the absence (2) or presence (1) of micrococcal nuclease for 10 min at 308C. RNA was isolated, separated in
a 14% polyacrylamide/8.3 M urea gel, and blotted onto a nylon membrane, followed by detection with oligonucleotides complementary
to different portions of U2 snRNA as indicated above each panel. The migration of DNA length markers is indicated on the left of the
figure. Please note that the DNA fragments migrate faster than the RNA fragments. Protected U2 snRNA fragments are indicated by
lines on the right side of each panel. 
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Oligonucleotides Sm, J, and C
 
9
 
 efficiently hybridized to
larger RNA fragments and the smaller fragment observed
in the 15S U2 snRNP disappeared. Changes in the protec-
tion of the 59 half of U2 snRNA (oligonucleotides A and
D) were mainly quantitative in nature, with the exception
of the smallest fragment present in the micrococcal nu-
clease digest of the 15S U2 snRNP but absent from the di-
gest of the 17S U2 snRNP. Moreover, oligonucleotide H
hybridized more efficiently to the two largest fragments;
thus, the protection in the 59 half of U2 snRNA extended
into the region encompassing nucleotides 70–78 of U2 sn-
RNA. These results suggest that the major site for interac-
tion of SF3a is the 39 portion of the U2 snRNP. The block
of the micrococcal nuclease-sensitive site between the se-
quences complementary to oligonucleotides Sm and J may
position SF3a relatively close to the Sm proteins. The
binding of SF3b is affected as well. Because incorporation
of SF3a into the U2 snRNP requires both SF3b and the
12S U2 snRNP (see above) it is possible that binding of
SF3b to the 59 half of U2 snRNA is stabilized by interac-
tion with SF3a. Major micrococcal nuclease-sensitive sites
were detected only in the region between oligonucleotides
H and Sm, i.e., between stem-loop IIb and the Sm-binding
site. Thus together, SF3a, SF3b, A9, B99, and the Sm pro-
teins appear to cover the U2 snRNA in the 17S U2 snRNP
almost entirely.
SF3b Represents a Distinct Globular Domain of the 15S 
and 17S U2 snRNPs
The morphology of the 12S and 17S U2 snRNPs has been
studied previously by electron microscopy. The 12S U2 sn-
RNP consists of two tightly attached domains (Fig. 5 B;
Kastner et al., 1990). A core domain of z8 nm in diameter
contains the Sm proteins and a slightly smaller head do-
main comprises the A9 and B99 proteins. The 17S U2 sn-
RNP displays a bipartite structure in which two globular
domains of 10–12 nm each are connected by a thin RNase-
sensitive filament (Fig. 5 A; Behrens et al., 1993b). Based
on the morphology and additional biochemical data, it was
suggested that one of these domains comprises a large part
of the 17S U2-specific proteins. The second domain should
contain the 12S U2 domain; however, characteristic fea-
tures of the 12S U2 snRNP were not apparent in either
globular structure of the 17S U2 particle. Based on the re-
sults presented above, one might expect that one of the
domains is built from the SF3b subunits whereas the sec-
ond domain could represent SF3a in association with the
12S domain of the U2 snRNP.
To test this assumption, glycerol gradient–purified SF3b
and 15S U2 snRNP were adsorbed onto carbon film, nega-
tively contrasted with uranyl formate and subjected to
electron microscopy. Preparations of SF3b displayed glob-
ular structures of uniform size with a diameter of 10–12 nm
(Fig. 5 D). Close inspection of the shape of the particles
and the accumulation of stain revealed structural details
such as indentations and dot-like or elongated high inten-
sity staining. Upon examination of z500 detailed views
seven representative forms of SF3b that account for
z80% of the images were distinguished. The images in
Fig. 6 A (forms I and II) showed a typical dot-like high in-
tensity stain, which was never located in the center but
found in the periphery of the particle. The images are ori-
ented such that the dot is visible in the upper third of the
structure. The dot was relatively small (,2 nm) with inten-
sive contrast (forms I and II) or larger (up to 5 nm) with an
extended appearance that followed the contour of the par-
ticle (form III). A thin filamentous structure protruding
from the left side was apparent in images of form III.
Structures with a line of stain (oriented horizontally in the
images shown) that bisects the particles were observed in
forms IV–VI. The line either separated the SF3b particle
into roughly two halves (form IV) or an upper third and a
lower two-thirds (forms V and VI). Forms V and VI ap-
peared as approximate mirror images with asymmetric bi-
secting lines that ended in an indentation on the left or
right side of the particles, respectively. The last class of
particles (from VII) was characterized by a single wedge-
shaped indentation oriented upwards in the images shown.
In summary, the SF3b protein complex has a globular ap-
pearance with a highly structured surface. The dot-like ac-
Figure 5. General view of the morphology of the 12S, 15S, and
17S U2 snRNPs and SF3b. Preparations of U2 snRNP particles
and SF3b were negatively contrasted with uranyl formate and
viewed by electron microscopy. (A) 17S U2 snRNP. Arrowheads
indicate the filamentous connection between the two globular
domains of the 17S U2 snRNP. (B) 12S U2 snRNP. Large arrows
point to the core domain of the 12S U2 snRNP and small arrows
point to the additional domain containing the A9 and B99 pro-
teins. (C) 15S U2 snRNP. (D) SF3b. Images of the 12S and 17S
U2 snRNPs were taken from previous studies (Kastner et al.,
1990; Behrens et al., 1993b).Krämer et al. Architecture of the U2 snRNP 1363
Figure 6. Characteristic images
of SF3b and the 15S U2 snRNP.
(A) Each panel (I–VII) shows
four examples of the seven prin-
cipal forms of SF3b with inter-
pretative sketches. The arrows
in images of form III indicate a
peripheral filamentous struc-
ture that can only be observed in
this type of projection. (B) Pan-
els I–VII show three examples
each of the 15S U2 snRNP with
characteristic views of SF3b.
The electron micrographs are
oriented such that they are com-
parable to those of SF3b shown
in A (except for form II). The
arrows in images of form III
indicate the filamentous struc-
ture that is typical for this type
of projection. Interpretative
sketches of the 15S U2 snRNPs
are shown below the images.
These sketches are compared
with those of SF3b (A); the
shaded area indicates the ex-
pected position of the 12S U2
snRNP domain. (C) Images of
the 15S U2 snRNP. Panels I–VI
show images of the 15S U2 sn-
RNP in which the characteristic
morphology of the 12S U2 sn-
RNP is visible. For comparison,
panel VII shows two images of
the 12S U2 snRNP. The roughly
round core domain of the 12S
U2 snRNP with the central dot
(visible only in some images) is
oriented close to the SF3b do-
main in the 15S U2 snRNP and
the domain containing A9 and
B99 is oriented upwards. Inter-
pretative sketches are shown be-
low the images. Bar, 20 nm.The Journal of Cell Biology, Volume 145, 1999 1364
cumulation of stain most likely represents a deep hole or
tunnel. The bisecting lines seen in other images could rep-
resent side views of such structure. On the other hand, the
bisecting line could result from accumulation of stain in a
surface furrow at the interface of two proteins.
Purified 15S U2 snRNP displayed a bipartite structure
in the electron microscope (Fig. 5 C). A globular domain
of z10–12 nm in diameter was connected by a thin fila-
ment to a second domain which was up to 12 nm long and
8 nm wide. The distance between the two domains mea-
sured up to 4 nm. The larger domain showed dot-like and
elongated areas of high intensity staining, very similar to
those observed with isolated SF3b (Fig. 6, A and B). In ad-
dition, the contours of different images of this domain
were comparable to those of SF3b, suggesting that the
large domain represents the SF3b component of the 15S
U2 snRNP. The smaller domain revealed many similarities
to the structure of the 12S U2 snRNP determined by Kast-
ner et al. (1990) (Fig. 6 C, panel VII). It consisted of a
main body of z8 nm in diameter and a closely attached
additional structure of 4 nm length and 6 nm width (Fig. 6
C, panels I–VI; the smaller domain of the 15S U2 snRNP
is oriented upwards). In addition, a central dot, which is a
characteristic feature of the snRNP core domain (Kastner
et al., 1990), was often visible in the main body.
A very close similarity was observed between the struc-
tures of the isolated 12S U2 snRNP and SF3b and the two
domains in the 15S U2 snRNP (Fig. 6). Therefore, it is
highly likely that the association between SF3b and the
12S U2 snRNP does not result in dramatic structural
changes within either of the individual components. Con-
sidering the distance between the 12S U2 and SF3b do-
mains visible in most images of the 15S U2 snRNP, direct
communication between the individual domains is proba-
bly limited. In the 15S U2 particle a thin filament always
connects SF3b to the 12S U2 snRNP core domain (Fig. 6
C). In the images shown, the connecting filament pro-
trudes from the left (forms I2IV) or right (forms V and
VI) bottom part of the core domain. The smaller structure
containing the A9 and B99 proteins is more distantly lo-
cated and found opposite of the SF3b domain in most
projections. Thus, direct contacts between the SF3b and
A9/B99 proteins are unlikely.
The connection to the 12S U2 domain with respect to
SF3b can be described as follows. In the SF3b images that
display dot-like staining the 12S U2 domain was either
found close to (Fig. 6 B, form I) or distant from (form II)
the stained dot. A close location was usually apparent
when the stained dot was large. The 12S U2 domain was
located at a distance from the extended structure of high
intensity stain in projections of form III. Similar to the cor-
responding images of isolated SF3b (Fig. 6 A, form III),
the filamentous protrusion was visible on the left side of
the particle. This protrusion was located in the lower part
of the particle but was clearly separated from the filament
that connects the 12S U2 to the SF3b domain. In forms
IV–VI, which are characterized by a bisecting line, the 12S
U2 domain was usually found close to the end of the line
(Fig. 6 B). Finally, in form VII the 12S U2 domain was lo-
cated opposite to the wedge-like indentation.
The distance between the SF3b and 12S U2 snRNP do-
mains varies considerably between different forms. The
connecting filament is clearly visible in those 15S U2 sn-
RNP images that display a maximal distance between the
two domains. In the example shown at higher magnifica-
tion in Fig. 7 A the connecting filament (with a width of
z2 nm) exits the core snRNP domain and appears to
branch out before connecting to the SF3b domain. Com-
pared with the 15S U2 snRNP the two domains of the 17S
U2 particle are closer to one another and the connecting
filament appears shorter and thicker (Fig. 7 D). The typi-
cal features of the 15S U2 snRNP cannot be recognized
in the 17S U2 domains, suggesting structural changes in
both domains upon conversion of the 15S into the 17S U2
snRNP.
In summary, the positioning of SF3a and SF3b inferred
from the nuclease protection experiment agrees well with
the morphology of the different particles visualized in the
electron microscope. In the 12S U2 snRNP only the 39 por-
tion of U2 snRNA is protected, consistent with the binding
of the Sm and A9/B99 proteins to the Sm-binding site and
stem-loop IV, respectively. Protection of the 59 half upon
binding of SF3b corresponds to the appearance of a novel
structural domain in the 15S U2 snRNP that is very similar
in size and shape to isolated SF3b (Fig. 7, A–C). Binding
of SF3a induces an extended protection in the 39 half of
U2 snRNA, which is reflected in a different appearance of
the 12S domain in the 17S U2 snRNP. In addition, the
shape of the SF3b portion of the U2 snRNP is changed in
the 17S U2 snRNP, which correlates with a more efficient
protection from micrococcal nuclease digestion in the 59
half of the U2 snRNA (Fig. 7, D–F).
Discussion
Comparison of polypeptides that are associated with the
purified 17S U2 snRNP and SF3a or precipitated from
spliceosomes with anti-U2 snRNP antibodies has previ-
ously suggested that SF3b consists of at least four subunits
of 49, 130, 145, and 155 kD (Behrens et al., 1993b; Brosi
et al., 1993a; Staknis and Reed, 1994). Here we have
demonstrated that SF3b purified from HeLa cell nuclear
extracts comprises four subunits of the expected sizes.
Polypeptides of identical apparent molecular mass are
highly enriched in glycerol gradient fractions of the 15S
U2 snRNP and these fractions substitute for the 12S U2
snRNP and SF3b activity in presplicing complex forma-
tion. Moreover, only the presumptive SF3b subunits are
precipitated from purified or reconstituted 17S U2 snRNP
with an antibody directed against SF3a66 in addition to
the SF3a subunits, 12S U2 snRNP-associated proteins, and
U2 snRNA.
Together, the SF3a and SF3b subunits account for seven
of the 17S U2 snRNP-specific proteins (Behrens et al.,
1993b). Similarly, anti-U2 snRNP antibodies precipitated
seven polypeptides in addition to the 12S U2 snRNP pro-
teins from a fraction enriched in U2 snRNP (Staknis and
Reed, 1994). This raises questions about the 35 and 92-kD
polypeptides found associated with the purified 17S U2 sn-
RNP by Behrens et al. (1993b). It is possible that these
proteins are even less tightly bound to the U2 snRNP than
SF3a and SF3b (Behrens et al., 1993b; Brosi et al., 1993a)
and dissociate from the remainder of the particle during
purification or immunoprecipitation procedures. The 35-Krämer et al. Architecture of the U2 snRNP 1365
and 92-kD proteins have not been detected in mAb66 im-
munoprecipitates of the 17S U2 snRNP, suggesting that
they are not required for SF3a, SF3b, and the 12S U2 sn-
RNP to remain stably associated with one another. How-
ever, this does not exclude the possibility that these pro-
teins function in the assembly of the 17S U2 snRNP or the
prespliceosome. Loss of the 35- and 92-kD proteins from
the 15S U2 snRNP or SF3b fractions during glycerol-gra-
dient sedimentation could, for example, explain the low
activity of these fractions in presplicing complex forma-
tion.
Brosi et al. (1993a) previously established that the 17S
U2 snRNP is formed in vitro by stepwise interactions of
SF3b and SF3a with the U2 snRNP. The results presented
here strongly suggest that the assembly pathway is initi-
ated by contacts of SF3b with the 59 half of U2 snRNA.
First, in the 12S U2 snRNP only the 39 terminal stem-loops
and the Sm-binding site are protected from micrococcal
nuclease digestion. In contrast, the region extending from
stem-loop I to stem-loop IIa (and to a lesser extent stem-
loop IIb) of U2 snRNA, which is fully accessible to mi-
crococcal nuclease digestion in the 12S U2 snRNP, is
protected in the reconstituted 15S U2 particle. Second,
treatment of the 12S U2 snRNP with micrococcal nuclease
before incubation with SF3a and SF3b prevents the assem-
bly of the 17S U2 snRNP, indicating that at least part of
the U2 snRNA is required for stable contacts. Moreover,
visualization by electron microscopy demonstrated that
the 15S U2 particle contains two structurally distinct do-
mains. The smaller domain exhibits the typical features of
the single domain of the 12S U2 snRNP, whereas the char-
acteristic structure of SF3b is conserved in the larger do-
main. The domains are connected by a thin filament,
which most likely represents U2 snRNA, in analogy to the
17S U2 snRNP where a corresponding connection is
RNase-sensitive (Behrens et al., 1993b).
The interpretation of these data is in agreement with
and extends results of previous studies. (Although the fol-
lowing results were obtained with the 17S U2 snRNP, we
believe that they reflect the situation of the 15S U2 parti-
cle, i.e., the binding of SF3b, because the differences in mi-
crococcal nuclease protection in the 59 half of U2 snRNA
in the 15S and 17S U2 snRNP were quantitative rather
than qualitative in nature [see Fig. 4 C].) Temsamani et al.
(1991) reconstituted the U2 snRNP in a cytoplasmic S100
extract from synthetic U2 snRNA. Upon incubation in nu-
clear extract the particles (which exhibited a high mobility
in native polyacrylamide gels) were converted to low mo-
bility complexes that almost certainly correspond to the
17S U2 snRNP. Oligonucleotide-directed RNase H cleav-
age of the 59 end of U2 snRNA and the branch site in-
teraction sequence before incubation in the nuclear ex-
tract abolished 17S U2 snRNP formation. Behrens et al.
(1993b) reported that the 59 end of the U2 snRNA was
cleaved more efficiently by RNase H in the presence of a
complementary oligonucleotide in the 17S than in the 12S
U2 snRNP. In addition, nucleotides C8 and C10 were
more accessible to chemical modification in the 17S than
in the 12S U2 snRNP. Together these data suggested a
structural change in the 59 portion of U2 snRNA upon
binding of the 17S U2-specific proteins that results in a
(partial) melting of stem I and thus an increase in the
potential for intermolecular base pairing. Furthermore,
strengthening of stem-loop I by mutation inhibited splic-
ing in a mammalian extract (Wu and Manley, 1992), which
could reflect an interference with the binding of SF3b. U2
snRNA sequences on both sides of stem I engage in base
pairing interactions with U6 snRNA (for review see Staley
Figure 7. Interpretation of the struc-
ture of the 15S and 17S U2 snRNP.
(A and D) Electron micrographs of
representative 15S and 17S U2 sn-
RNPs with a well visible connection
between the two domains. (B and E)
Interpretative sketches of the 15S
and 17S U2 snRNP images. (C and F)
Models of the architecture of the 15S
and 17S U2 snRNPs indicating the lo-
calization of the SF3b protein com-
plex, the 12S U2 snRNP core, and
A9/B99 domains, and SF3a in the 17S
U2 snRNP particle. In addition, a
projection of the structure of the U2
snRNA in the RNP is shown. Sm-
site, binding site of the core proteins;
bp-site, region complementary to the
intron branch site; cap, tri-meth-
ylated cap structure of U2 snRNA.
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and Guthrie, 1998). Therefore, it is intriguing to speculate
that one or more SF3b subunits are directly involved in
presenting this region of U2 to U6 snRNA for the forma-
tion of helix Ia/Ib which is an essential element of the cata-
lytic center of the spliceosome both in mammals and yeast.
The protection of the region encompassing stem-loop
IIa in the 15S (and 17S) U2 snRNP is in good agreement
with the result that chemical modification of nucleotides
C40, G42, and C45 is less efficient in the 17S than the 12S
U2 snRNP (Behrens et al., 1993b). Moreover, deletion of
nucleotides 46–49 prevents the assembly of the 17S U2 sn-
RNP (Temsamani et al., 1991). In addition, a mutation in
Cus1p, the S. cerevisiae homologue of SF3b145 (Gozani
et al., 1996; Wells et al., 1996), suppresses mutations in
yeast U2 snRNA that correspond to nucleotides 39–44, 52,
and 61 of human U2 snRNA (Wells et al., 1996; Yan and
Ares, 1996). Based on these results and the evolutionary
conservation of SF3b145 and Cus1p (Gozani et al., 1996;
Wells et al., 1996) we assume that the protection of stem-
loop IIa reflects the binding of SF3b145. Preliminary evi-
dence indicates that SF3b145, SF3b49, and one of the
other large SF3b subunits cross-link to U2 snRNA (Grön-
ing, K., and A. Krämer, unpublished observation). More-
over, Cus1p is apparently associated with an RNA-binding
activity (see Igel et al., 1998). Thus, it is highly likely that
SF3b145 binds directly to stem-loop IIa of U2 snRNA.
Whether or not the branch site interaction sequence of
U2 snRNA is involved in interactions with the SF3b sub-
units is unclear. We have not detected any micrococcal nu-
clease-sensitive sites between stem-loops I and IIa in the
15S or 17S U2 snRNPs. However, this region is equally
well accessible to oligonucleotide-targeted RNase H di-
gestion and chemical modification in the 12S and 17S U2
snRNPs (Behrens et al., 1993b). This discrepancy could be
explained by a different availability of the branch site in-
teraction region to oligonucleotide-targeted RNase H or
micrococcal nuclease digestion or to relatively mild condi-
tions used for nuclease treatment in this report. The obser-
vation that U2 snRNAs carrying mutations within the
branch site interaction region fail to assemble into the 17S
U2 snRNP (Temsamani et al., 1991) argues in favor of a
contribution of these sequences to the assembly of the ac-
tive U2 snRNP. Clearly, this issue needs further clarifica-
tion.
During the formation of the 15S U2 snRNP we also ob-
served changes in the protection pattern in the 12S do-
main, in that the protection of stem-loops III and IV is
more efficient and a weak protection of the Sm-binding
site is apparent. Equivalent changes in the structure of the
subdomains of the 15S U2 snRNP compared with isolated
SF3b or the 12S U2 snRNP are not visible in the electron
microscope. In fact, the domain containing the A9 and B99
proteins appears to be located at a distance from the SF3b
domain; therefore, we believe that direct contacts between
these proteins are limited. Although we cannot rule out in-
teractions between SF3b and the Sm proteins that may not
be resolved in the electron microscope, we favor the no-
tion that binding of SF3b to the 59 half of U2 snRNA re-
sults in a subtle conformational change in the 12S domain.
SF3a does not stably interact with either SF3b or the 12S
U2 snRNP alone (Brosi et al., 1993a; data presented here),
indicating that both components contribute to the binding
site for SF3a. Consistent with this, in the 17S U2 snRNP
we observed an extended protection from micrococcal nu-
clease digestion that encompasses the Sm binding site and
stem-loops III and IV of U2 snRNA as well as a more effi-
cient protection of the 59 half. In addition, we observed
differences in the morphology of the 17S U2 snRNP in the
electron microscope. Like the 15S U2 snRNP, the 17S par-
ticle is composed of two domains, both of which approxi-
mately correspond in size to the SF3b domain of the 15S
U2 snRNP. However, structural details of neither the
SF3b nor 12S domain are apparent in the two globular
structures of the 17S U2 particle. Together, the results
from micrococcal nuclease protection and electron micro-
scopic analysis suggest that the main binding site for SF3a
is the 12S domain of the U2 snRNP, thus contributing to
the increase in size. The chemical modification pattern in
the 39 half of U2 snRNA was identical in the 12S and 17S
U2 snRNP (Behrens et al., 1993b), which was interpreted
to mean that most 17S U2 snRNP-specific proteins associ-
ate with the 59 portion of the U2 snRNP. On the other
hand, it is possible that binding of SF3a does not occur
by tight protein–RNA interactions or induce substantial
structural changes in the RNA, but may rely mainly on
protein–protein interactions. Good candidates for inter-
acting proteins are the A9 and/or B99 proteins, because de-
letion of their binding site (nucleotides 154–167) prevents
the assembly of the 17S U2 snRNP (Temsamani et al.,
1991). Thus, the integrity of the 39 end of U2 snRNA and/or
the presence of the A9 and B99 proteins may be necessary
for binding of SF3a. An interaction of SF3a with these pro-
teins (or this region of U2 snRNA) may also explain why
U2 snRNAs carrying mutations in loop IV were inactive in
mammalian splicing (Wu and Manley, 1992). Contacts
with the Sm proteins are also possible, given that no mi-
crococcal nuclease sensitive sites were detected between
stem-loop IV and the Sm-binding site. In fact, the ma-
jor micrococcal nuclease-sensitive site between sequences
complementary to oligonucleotides Sm and J in the 15S
U2 snRNP is completely protected in the 17S U2 particle,
which locates SF3a close to the Sm proteins.
The increased efficiency of micrococcal nuclease protec-
tion in the 59 half of U2 snRNA observed upon binding of
SF3a can be interpreted by stabilization of the interaction
of SF3b with the U2 snRNA. This could either be the re-
sult of a structural change induced by binding of SF3a to
the 39 portion of U2 snRNP or by direct contacts between
the SF3a and SF3b subunits. The idea of direct contacts
between these proteins is supported by the result that the
SF3a and SF3b subunits as well as the B99, B, and B9 pro-
teins are coprecipitated after micrococcal nuclease diges-
tion of the reconstituted 17S U2 snRNP. Evidence for in-
teractions between SF3a and SF3b or U2 snRNA comes
from studies in S. cerevisiae. First, mutations in homo-
logues of the SF3a subunits (Prp9p, Prp11p, and Prp21p)
are synthetic lethal with a number of mutations in stem-
loops IIa and IIb of U2 snRNA and the region between
the branch site interaction sequence and stem-loop IIa
(Ruby et al., 1993; Wells and Ares, 1994; Yan and Ares,
1996). The same pattern of phenotype was observed with
all three mutant proteins, which suggested that they inter-
acted with the U2 snRNP as a functional unit. A candidate
for interaction is Cus1p, the homologue of SF3b145. Muta-Krämer et al. Architecture of the U2 snRNP 1367
tions in Cus1p suppressed mutations in U2 snRNA down-
stream of the branch site interaction sequence and in
stem-loop IIa (Wells et al., 1996; Yan and Ares, 1996). The
synthetic lethality between mutations in the SF3a subunits
and stem IIb (Wells and Ares, 1994) may also explain the
weak but apparent protection within this region. Second,
extra copies of wild-type Cus1p partially suppressed the
growth defect of prp11-1, but not prp9-1 or prp21-1, sug-
gesting interactions between SF3b145 and SF3a66 (Wells
et al., 1996). Third, in a yeast two-hybrid screen the gene
product of Yml049c, which represents the yeast ortho-
logue of SF3b130 (Caspary et al., 1999; Krämer, A., un-
published data), was found as a partner of Prp9p (SF3a60;
Fromont-Racine et al., 1997).
Given these possible interactions, it may be surprising
that the 17S U2 snRNP consists of two distinct globular
domains in the electron microscope (Fig. 7 D; Behrens et al.,
1993b). On the one hand, this discrepancy could be ex-
plained if interactions between SF3a and SF3b were indi-
rect and merely resulted in a structural change of the SF3b
domain, which may be reflected in a loss of the typical fea-
tures of this domain upon formation of the 17S U2 snRNP.
On the other hand, interactions between SF3a and SF3b
could be relatively weak and thus not be visible in the elec-
tron microscope. Another possibility is that protein–pro-
tein contacts involve structures that are beyond the detec-
tion limit of the electron microscope.
In summary, the combined data from biochemical and
electron microscopic analyses can be incorporated into a
model in which SF3b initiates the assembly of the active
U2 snRNP by interactions with the 59 half of U2 snRNA,
which positions this splicing factor close to U2 snRNA se-
quences that are essential for the catalysis of splicing. SF3a
then associates with the 39 portion of the U2 snRNP and,
most likely, directly interacts with one or more of the SF3b
subunits.
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